Image by Marko Geber/Getty Visuals
Pfizer and BioNTech have formally requested that their COVID-19 vaccine be cleared for use amongst young little ones.
In a tweet Thursday, Pfizer mentioned the businesses submitted their ask for for an emergency use authorization (EUA) of their vaccine to the U.S. Foodstuff and Drug Administration. They are looking for clearance for it to be utilised amongst little ones aged 5 to eleven decades old.
The ask for for EUA will be evaluated through an impending Vaccines and Connected Biological Solutions Advisory Committee (VRBPAC) meeting on Oct 26.
“We know from our extensive experience with other pediatric vaccines that little ones are not tiny grown ups, and we will carry out a extensive analysis of medical demo knowledge submitted in support of the safety and usefulness of the vaccine utilised in a youthful pediatric population, which could will need a different dosage or formulation from